Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
JNJ-53718678 in adult and adolescent hematopoietic stem cell transplant recipients with RSV infection
MOH_2020-02-17_008666Phase 2Completed
- Sponsor
- Janssen Sciences Ireland
- Start
- Feb 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in respiratory syncytial virus disease (RSV) comparing JNJ-53718678 with Placebo (2 arms). Started Feb 2020; status: completed.
02
Drugs
rilematovir
03
Conditions
respiratory syncytial virus disease (RSV)
Beyond the preview
Go deeper on MOH_2020-02-17_008666.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on MOH_2020-02-17_008666.